Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a, 2-part,Randomized, Double-blind, Placebo-controlled, Incomplete Block Crossover Study to Evaluate the Safety and Efficacy of VX-371 Solution for Inhalation With and Without Oral Ivacaftor in Subjects With Primary Ciliary Dyskinesia

NCT02871778 is registered in ClinicalTrials.gov with Parion Sciences as lead sponsor.

NCT NCT02871778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02871778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a, 2-part,Randomized, Double-blind, Placebo-controlled, Incomplete Block Crossover Study to Evaluate the Safety and Efficacy of VX-371 Solution for Inhalation With and Without Oral Ivacaftor in Subjects With Primary Ciliary Dyskinesia
Lead sponsor
Parion Sciences
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2016
Completion date
November 20, 2018
Enrollment
123 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

primary ciliary dyskinesia